Tuesday, August 22, 2017 4:44:57 PM
https://ryortho.com/2017/08/the-ten-best-sports-medicine-technologies-for-2017/
The Ten Best Sports Medicine Technologies for 2017
Rewarding Innovation and Perspiration
This annual award rewards inventors, engineering teams, physicians and their companies who’ve created the most innovative, enduring and practical products in 2016 to treat injured athletes in ANY activity—whether sports, industry, military or healthcare. To win the Orthopedics This Week Best New Technology Award for sports medicine care, a new technology must meet the following criteria:
Be creative and innovative.
Have long term significance to the problem of treating the injured athlete. Does this technology have staying power?
Solve a clinical problem. To what extent does this technology solve a current clinical problem or problem that is inadequately solved today?
Does it have the potential to improve standard of care?
Is it cost effective?
I would use it
Our panel of physicians score every submission on a scale of 1 to 5 (5 being the highest score) for each of the above criteria.
We and our panel of surgeons were impressed that inventors—despite ever growing hurdles to innovation and entrepreneurism in medicine—still managed to create a solid group of nearly 30 new products to submit for the 2017 Orthopedics This Week Sports Medicine Technology Awards.
BioElectronics Corporation
Winning Technology: ActiPatch (Pulsed Shortwave Therapy)
Inventor: John Martinez
Engineers: John Martinez, Sree Koneru, Ph.D.
ActiPatch device is a wearable, low-power, pulsed shortwave therapy device for adjunctive treatment of osteoarthritis of the knee and plantar fasciitis. ActiPatch emits a low level, pulsed electromagnetic energy field over the treatment site at a frequency in the 27.1 MHz ISM band and is pulsed-modulated at 1 KHz with a duty cycle of 10%. The battery supplies power for 720 hours.
The high-frequency, low-power nature of the stimulus means that users experience no sensations of any kind. Chronic pain results from the process of sensitization of the underlying nerves, which most often occurs when high levels of acute pain are sustained for an extended time-period. When sustained tissue insult or injury sensitizes the central nervous system even non-painful stimuli can produce painful responses. This process occurs in the spine of the individual, which is considered part of the central nervous system, and so is referred to as “central sensitization.” Central sensitization is associated with a wide variety of pain conditions, including osteoarthritis of the knee pain, neck pain, low back pain, dysmenorrhea, fibromyalgia, myofascial pain, migraines and painful bladder, among many others. Providing continuous, new information to peripheral nerves is key to mitigating central sensitization, and this is accomplished by the ActiPatch.
Never buy/sell a stock on my recommendation alone. Always do your own DD and be aware of the risks!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM